TABLE 1 LAMEA Castrate-resistant Prostate Cancer Market, 2016 - 2019, USD Million
TABLE 2 LAMEA Castrate-resistant Prostate Cancer Market, 2020 - 2026, USD Million
TABLE 3 LAMEA Castrate-resistant Prostate Cancer Market by Therapy, 2016 - 2019, USD Million
TABLE 4 LAMEA Castrate-resistant Prostate Cancer Market by Therapy, 2020 - 2026, USD Million
TABLE 5 LAMEA Hormonal Therapy Market by Country, 2016 - 2019, USD Million
TABLE 6 LAMEA Hormonal Therapy Market by Country, 2020 - 2026, USD Million
TABLE 7 LAMEA Immunotherapy Market by Country, 2016 - 2019, USD Million
TABLE 8 LAMEA Immunotherapy Market by Country, 2020 - 2026, USD Million
TABLE 9 LAMEA Chemotherapy Market by Country, 2016 - 2019, USD Million
TABLE 10 LAMEA Chemotherapy Market by Country, 2020 - 2026, USD Million
TABLE 11 LAMEA Radiotherapy Market by Country, 2016 - 2019, USD Million
TABLE 12 LAMEA Radiotherapy Market by Country, 2020 - 2026, USD Million
TABLE 13 LAMEA Castrate-resistant Prostate Cancer Market by Country, 2016 - 2019, USD Million
TABLE 14 LAMEA Castrate-resistant Prostate Cancer Market by Country, 2020 - 2026, USD Million
TABLE 15 Brazil Castrate-resistant Prostate Cancer Market, 2016 - 2019, USD Million
TABLE 16 Brazil Castrate-resistant Prostate Cancer Market, 2020 - 2026, USD Million
TABLE 17 Brazil Castrate-resistant Prostate Cancer Market by Therapy, 2016 - 2019, USD Million
TABLE 18 Brazil Castrate-resistant Prostate Cancer Market by Therapy, 2020 - 2026, USD Million
TABLE 19 Argentina Castrate-resistant Prostate Cancer Market, 2016 - 2019, USD Million
TABLE 20 Argentina Castrate-resistant Prostate Cancer Market, 2020 - 2026, USD Million
TABLE 21 Argentina Castrate-resistant Prostate Cancer Market by Therapy, 2016 - 2019, USD Million
TABLE 22 Argentina Castrate-resistant Prostate Cancer Market by Therapy, 2020 - 2026, USD Million
TABLE 23 UAE Castrate-resistant Prostate Cancer Market, 2016 - 2019, USD Million
TABLE 24 UAE Castrate-resistant Prostate Cancer Market, 2020 - 2026, USD Million
TABLE 25 UAE Castrate-resistant Prostate Cancer Market by Therapy, 2016 - 2019, USD Million
TABLE 26 UAE Castrate-resistant Prostate Cancer Market by Therapy, 2020 - 2026, USD Million
TABLE 27 Saudi Arabia Castrate-resistant Prostate Cancer Market, 2016 - 2019, USD Million
TABLE 28 Saudi Arabia Castrate-resistant Prostate Cancer Market, 2020 - 2026, USD Million
TABLE 29 Saudi Arabia Castrate-resistant Prostate Cancer Market by Therapy, 2016 - 2019, USD Million
TABLE 30 Saudi Arabia Castrate-resistant Prostate Cancer Market by Therapy, 2020 - 2026, USD Million
TABLE 31 South Africa Castrate-resistant Prostate Cancer Market, 2016 - 2019, USD Million
TABLE 32 South Africa Castrate-resistant Prostate Cancer Market, 2020 - 2026, USD Million
TABLE 33 South Africa Castrate-resistant Prostate Cancer Market by Therapy, 2016 - 2019, USD Million
TABLE 34 South Africa Castrate-resistant Prostate Cancer Market by Therapy, 2020 - 2026, USD Million
TABLE 35 Nigeria Castrate-resistant Prostate Cancer Market, 2016 - 2019, USD Million
TABLE 36 Nigeria Castrate-resistant Prostate Cancer Market, 2020 - 2026, USD Million
TABLE 37 Nigeria Castrate-resistant Prostate Cancer Market by Therapy, 2016 - 2019, USD Million
TABLE 38 Nigeria Castrate-resistant Prostate Cancer Market by Therapy, 2020 - 2026, USD Million
TABLE 39 Rest of LAMEA Castrate-resistant Prostate Cancer Market, 2016 - 2019, USD Million
TABLE 40 Rest of LAMEA Castrate-resistant Prostate Cancer Market, 2020 - 2026, USD Million
TABLE 41 Rest of LAMEA Castrate-resistant Prostate Cancer Market by Therapy, 2016 - 2019, USD Million
TABLE 42 Rest of LAMEA Castrate-resistant Prostate Cancer Market by Therapy, 2020 - 2026, USD Million
TABLE 43 Key Information – Sanofi S.A.
TABLE 44 Key information –Johnson and Johnson
TABLE 45 Key Information – Pfizer, Inc.
TABLE 46 Key Information – Bayer AG
TABLE 47 Key Information – Abbott Laboratories
TABLE 48 Key Information – GlaxoSmithKline PLC (GSK)
TABLE 49 Key Information – Northwest Biotherapeutics, Inc.
TABLE 50 Key Information – Active Biotech AB
TABLE 51 key information – Astellas Pharma, Inc.
TABLE 52 Key Information – Dendreon Pharmaceuticals LLC
List of Figures
FIG 1 Methodology for the research
Unique Offerings 